< 生产厂家价格 >

1H,1H,2H,2H-全氟辛醇

1H,1H,2H,2H-全氟辛醇名称

[ CAS 号 ]:
647-42-7

[ 中文名 ]:
3,3,4,4,5,5,6,6,7,7,8,8,8-十三氟-1-辛醇

[ 英文名 ]:
3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluoro-1-octanol

[中文别名 ]:

[英文别名 ]:

3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctan-1-ol
MFCD00042143
1H,1H,2H,2H-Perfluorooctan-1-ol
3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluoro-1-octanol
EINECS 211-477-1
1H,1H,2H,2H-Perfluorooctanol
1H, 1H, 2H, 2H-Perfluorooctan-1-ol

1H,1H,2H,2H-全氟辛醇物理化学性质

[ 密度 ]:
1.6±0.1 g/cm3

[ 沸点 ]:
174.1±0.0 °C at 760 mmHg

[ 分子式 ]:
C₈H₅F₁₃O

[ 分子量 ]:
364.104

[ 闪点 ]:
91.7±0.0 °C

[ 精确质量 ]:
364.013275

[ PSA ]:
20.23000

[ LogP ]:
4.16

[ 外观性状 ]:
无色液体

[ 蒸汽压 ]:
0.4±0.7 mmHg at 25°C

[ 折射率 ]:
1.298

[ 储存条件 ]:
室温

1H,1H,2H,2H-全氟辛醇MSDS

1H,1H,2H,2H-全氟辛醇安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H315-H319-H335

[ 警示性声明 ]:
P261-P305 + P351 + P338

[ 个人防护装备 ]:
Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ 危害码 (欧洲) ]:
Xi:Irritant;

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
S26-S37/39

[ 危险品运输编码 ]:
NA 1993 / PGIII

[ WGK德国 ]:
1

[ 海关编码 ]:
2905590090

1H,1H,2H,2H-全氟辛醇合成路线

1H,1H,2H,2H-全氟辛醇上下游产品

1H,1H,2H,2H-全氟辛醇上游产品

1H,1H,2H,2H-全氟辛醇下游产品

1H,1H,2H,2H-全氟辛醇海关

[ 海关编码 ]: 2905590090

[ 中文概述 ]:
2905590090 其他无环醇的卤化、磺化等衍生物。监管条件:无。增值税率:17.0%。退税率:9.0%。最惠国关税:5.5%。普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 包装

[ Summary ]:
2905590090 other halogenated, sulphonated, nitrated or nitrosated derivatives of acyclic alcohols。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:5.5%。General tariff:30.0%

1H,1H,2H,2H-全氟辛醇文献

Single-cell screening of photosynthetic growth and lactate production by cyanobacteria.

Biotechnol. Biofuels 8 , 193, (2015)

Photosynthetic cyanobacteria are attractive for a range of biotechnological applications including biofuel production. However, due to slow growth, screening of mutant libraries using microtiter plate...

Sustained release of hydrophobic drugs by the microfluidic assembly of multistage microgel/poly (lactic-co-glycolic acid) nanoparticle composites.

Biomicrofluidics 9 , 052601, (2015)

The poor solubility of many newly discovered drugs has resulted in numerous challenges for the time-controlled release of therapeutics. In this study, an advanced drug delivery platform to encapsulate...

更多文献